Skip to main content
SpringerLink
Log in

Identification of risk factors and characteristics of supraclavicular lymph node metastasis in patients with small cell lung cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Thoracic radiotherapy provides a survival benefit in patients with limited-stage disease of small cell lung cancer (LS-SCLC), but inclusion and exclusion of prophylactic irradiation of the supraclavicular area are still controversial. This study analyses the risk factors and characteristics of lymph node metastases in the supraclavicular area of LS-SCLC patients, which could help in developing a better radiotherapy for the patients. A total of 239 patients with LS-SCLC were included in this retrospective analysis. Clinical characteristics and mediastinal lymph node metastasis were analyzed for association with SCM, and the SCM pattern was further analyzed based on the treatment planning CT scans. The SCM incidence was 34.7 % (83 of 239). The multivariate analysis showed that only the mediastinal level 2 (OR = 16.101, P = 0.000) and level 3 (OR = 5.597, P = 0.000) lymph node metastases were significantly associated with SCM. As the most frequently involved region, supraclavicular level I lymph node metastases were identified in 61 of 83 patients (73.5 %), followed by level III, level IV, level V, and level II lymph node metastases, accounting a total of 95.2 % for level I and/or III lymph node metastases, whereas the incidence of skip metastasis was only 4.8 %. SCLC patients with mediastinal level 2 and level 3 lymph node metastasis were at high risk of SCM. If prophylactic irradiation therapy is considered, the nodal clinical target volume of irradiation should include bilateral lower para-recurrent laryngeal neural region (level I) and the para-internal jugular venous region (level III).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24:4539–44.

    Article  PubMed  Google Scholar 

  2. Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC. Small cell lung cancer: have we made any progress over the last 25 years? Oncologist. 2007;12(9):1096–104.

    Article  PubMed  Google Scholar 

  3. Videtic GM, Belderbos JS, Kong F, Kepka L, Martel MK, Jeremic B. Report from the International Atomic Energy Agency (IAEA) consultants’ meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys. 2008;72(2):327–34.

    Article  PubMed  Google Scholar 

  4. Rosenman JG, Xie L, Marks LB. Selective elective nodal irradiation: “let’s head’em off at the pass”. Int J Radiat Oncol Biol Phys. 2011;81(5):1208–10.

    Article  PubMed  Google Scholar 

  5. Tada T, Minakuchi K, Koda M, Masuda N, Matsui K, Kawase I, Nakajima T, Nishioka M, Fukuoka M, Kozuka T. Limited-stage small cell lung cancer: local failure after chemotherapy and radiation therapy. Radiology. 1998;208(2):511–5.

    PubMed  CAS  Google Scholar 

  6. De Ruysscher D, Bremer RH, Koppe F, Wanders S, van Haren E, Hochstenbag M, Geeraedts W, Pitz C, Simons J, Ten VG, Dohmen J, Snoep G, Boersma L, Verschueren T, van Baardwijk A, Dehing C, Pijls M, Minken A, Lambin P. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. Radiother Oncol. 2006;80(3):307–12.

    Article  PubMed  Google Scholar 

  7. Hu X, Bao Y, Zhang L, Guo Y, Chen YY, Li KX, Wang WH, Liu Y, He H, Chen M. Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial. Cancer. 2012;118(1):278–87.

    Article  PubMed  Google Scholar 

  8. Micke P, Faldum A, Metz T, Beeh KM, Bittinger F, Hengstler JG, Buhl R. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer–what limits limited disease? Lung Cancer. 2002;37(3):271–6.

    Article  PubMed  Google Scholar 

  9. Stahel R, Ginsberg R, Havemann K. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer. 1989;5:119–26.

    Article  Google Scholar 

  10. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–77.

    Article  PubMed  Google Scholar 

  11. Som PM, Curtin HD, Mancuso AA. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg. 1999;125(4):388–96.

    PubMed  CAS  Google Scholar 

  12. Li CL, Wang YD, Han C, Liu Q, Sun GG, Cheng YJ, Jing SW, Yang CR. Metastatic characteristics of lymph node in cervical region on and radiotherapy target volume after dissection of thoracic esophageal carcinoma. Chin J Radiat Oncol. 2012;21(2):126–9.

    CAS  Google Scholar 

  13. Gao YJ, Gao RT, Xu XY, Ge XF, Cui SR. Related factor analysis of lung cancer. Chin J Radiat Oncol. 1993;2(2):23–5.

    Google Scholar 

  14. Van Overhagen H, Brakel K, Heijenbrok MW, van Kasteren JH, van de Moosdijk CN, Roldaan AC, van Gils AP, Hansen BE. Metastases in supraclavicular lymph nodes in lung cancer: assessment with palpation, US, and CT. Radiology. 2004;232(1):75–80.

    Article  PubMed  Google Scholar 

  15. Li RJ, Zhao LJ, Gong LL, Wang P. The significance of the characteristics of intra-thoracic lymph node metastasis for radiotherapy range in small cell lung cancer. Chin J Radiat Oncol. 2011;20(6):479–82.

    Google Scholar 

  16. Taylor A, Rockall AG, Reznek RH, Powell ME. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63(5):1604–12.

    Article  PubMed  Google Scholar 

  17. Shih HA, Harisinghani M, Zietman AL, Wolfgang JA, Saksena M, Weissleder R. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys. 2005;63(4):1262–9.

    Article  PubMed  Google Scholar 

  18. Carolyn H, Kim MD, Adam C, Olson BA, Hayeon Kim MS. Contouring inguinal and femoral nodes; how much margin is needed around the vessels? Pract Radiat Oncol. 2012;2(4):274–8.

    Article  Google Scholar 

  19. van Loon J, De Ruysscher D, Wanders R, Boersma L, Simons J, Oellers M, Dingemans AM, Hochstenbag M, Bootsma G, Geraedts W, Pitz C, Teule J, Rhami A, Thimister W, Snoep G, Dehing-Oberije C, Lambin P. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2010;77(2):329–36.

    Article  PubMed  Google Scholar 

  20. Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol. 2004;22(16):3248–54.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Key Laboratory of Cancer Prevention and Therapy, Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China

    Zhen-Xing Feng, Lu-Jun Zhao, Yong Guan, Yao Sun, Mao-Bin Meng, Kai Ji & Ping Wang

Authors
  1. Zhen-Xing Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lu-Jun Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yong Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yao Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mao-Bin Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kai Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ping Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feng, ZX., Zhao, LJ., Guan, Y. et al. Identification of risk factors and characteristics of supraclavicular lymph node metastasis in patients with small cell lung cancer. Med Oncol 30, 493 (2013). https://doi.org/10.1007/s12032-013-0493-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0493-z

Keywords

Search

Navigation